Unreliable antibody tests flood the market as FDA waives quality reviews

The current FDA commissioner, Stephen Hahn, told POLITICO that the agency has discussed changing the current policy, which allows manufac...



The current FDA commissioner, Stephen Hahn, told POLITICO that the agency has discussed changing the current policy, which allows manufacturers to validate the quality of their own products as long as they include a disclaimer with test results. The FDA is trying to balance concerns about quality with its desire to allow innovative tests to reach the market quickly during a pandemic, he said.

It is not clear how any changes to the agency’s existing policy would affect the more than 155 antibody tests now available.

The FDA formally warned health care providers April 17 of the concerns surrounding the bulk of the antibody tests available for sale, explaining that it “does not review the validation, or accuracy, data for these tests unless an EUA is submitted.”

Hahn told POLITICO that an emergency-use authorization “is the process that gives us confidence in a test.” It is still faster and less rigorous than securing FDA approval for a new diagnostic test. That process typically takes more than a year, from the initial test development to the agency’s final decision, and requires companies to submit significantly more data.

FDA observers say the weak standards for antibody tests appear to be a response to critics who said the agency was too slow to approve coronavirus diagnostic tests in the early months of the outbreak.

Former FDA lawyer Coleen Klasmeier said the agency swung too far the other way. She said FDA needs to set tougher quality standards for specificity — which measures how often a test correctly produces positive results — and sensitivity, which measures how often a test correctly produces negative results.

Another approach would be to require companies to regularly submit data to prove their tests are accurate, said Klasmeier, now a partner at the law firm Sidley Austin.

Scott Becker, the CEO of the Association of Public Health Laboratories, has criticized the FDA for allowing “crappy” antibody tests onto the market without adequate review. “Ideally they would scrap the current policy and start over, but I don’t think that’s practical given this crisis,” he said. “The best we can hope for is a rigorous and expansive evaluation.”

And that might be coming. The FDA recently launched a program with the Centers for Disease Control and Prevention, the National Cancer Institute and National Institutes of Health that allows test manufacturers to have their products independently assessed for accuracy.

FDA diagnostics chief Tim Stenzel said several companies are already participating. “We will make results known as soon as we find a way to do that,” Stenzel said on a webinar Wednesday. “We will just say that some of this information is proprietary.”

Stenzel also said the FDA has “nearly completed” a template to make it easier for antibody test developers to apply for an emergency use authorization. The template will set out some minimum standards for sensitivity and specificity, he added.

Efforts to improve antibody tests also got a boost from the coronavirus aid package signed into law Friday, which provides the NCI with $306 million to help develop, assess and improve the tests.

Source link

COMMENTS

Name

Africa,725,Americas,3893,Art & Culture,14192,Arts,6327,Arts & Design,1518,Asia,3109,Automobile,413,Baseball,498,Basketball,396,Books,3719,Business,5160,Celebrity,2586,Cricket,599,Crime,116,Cryptocurrency,1383,Dance,585,Defense,792,Diplomatic Relations,2445,Economy,1002,Editorial,260,Education,1112,Elections,289,Energy & Environment,2984,Entertainment,22054,Environment,3464,Europe,4057,Faith & Religion,204,Family & Life,769,Fashion & Style,3079,Finance,18920,Food & Drink,3569,Football,1020,Games,73,Gossip,10240,Health & Fitness,3910,Health Care,865,Hockey,181,Home & Garden,874,Humour,946,Latin America,49,Lifestyle,16187,Media,487,Middle East,1396,Movies,1581,Music,2479,Opinion,2723,Other,11189,Other Sports,4861,Political News,11223,Political Protests,2273,Politics,17247,Real Estate,1680,Relationship,63,Retail,3064,Science,2466,Science & Tech,9462,Soccer,158,Space & Cosmos,270,Sports,11354,Technology,3262,Tennis,500,Theater,1556,Transportation,272,Travel,2436,TV,3523,US Sports,1428,Video News,3531,War & Conflict,1019,Weird News,951,World,15526,
ltr
item
Newsrust: Unreliable antibody tests flood the market as FDA waives quality reviews
Unreliable antibody tests flood the market as FDA waives quality reviews
https://static.politico.com/b6/c3/c204ebd24609a7ce7c58e5194877/200424-fda-ap-773.jpg
Newsrust
https://www.newsrust.com/2020/04/unreliable-antibody-tests-flood-market.html
https://www.newsrust.com/
https://www.newsrust.com/
https://www.newsrust.com/2020/04/unreliable-antibody-tests-flood-market.html
true
732247599994189300
UTF-8
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content